• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种由猴痘病毒A29L、M1R、A35R和B6R组成的亚单位候选疫苗在小鼠中引发强烈免疫反应。

A Subunit Vaccine Candidate Composed of Mpox Virus A29L, M1R, A35R, and B6R Elicits Robust Immune Response in Mice.

作者信息

Yang Xuetao, Yang Xidan, Du Shouwen, Hu Congxia, Yang Xiu, Wang Xingyun, Hu Xing, Rcheulishvili Nino, Wang Peng George, Lin Jihui

机构信息

School of Nursing, Southwest Medical University, Luzhou 646000, China.

Pengbo Biotechnology Co., Ltd., Shenzhen 518000, China.

出版信息

Vaccines (Basel). 2023 Aug 25;11(9):1420. doi: 10.3390/vaccines11091420.

DOI:10.3390/vaccines11091420
PMID:37766097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10537547/
Abstract

With no specific antiviral drugs and preventive vaccines against Mpox virus (MPXV), the epidemic has led to the declaration of a Public Health Emergency of International Concern. As a developmental direction for new vaccines, studies of subunit vaccines based upon MPXV antigen proteins are lacking. In this study, A29L, M1R, A35R, and B6R of MPXV were expressed and purified from a prokaryotic system. The four MPXV antigen proteins in combination were mixed with aluminum hydroxide or CpG7909 as adjuvant, and subsequently used to inoculate mice. The results of enzyme-linked immunosorbent assay (ELISA), flow cytometry analyses, and enzyme-linked immunospot (ELISPOT) assays indicated that A29L, M1R, A35R, and B6R elicited high-level antigen-specific antibodies and CD4 T cells-based cellular immune response in mice. Moreover, the results of virus neutralization assays suggested that sera from the mice immunized with four proteins elicited high neutralizing activities against the vaccinia virus. Notably, the results of ELISA, ELISPOT, and virus neutralization assays also showed that the CpG7909 adjuvant was more effective in inducing an immune response compared with the aluminum adjuvant. In summary, this study offers valuable insights for further studies of subunit vaccine candidates for the prevention of MPXV and other orthomyxoviruses.

摘要

由于缺乏针对猴痘病毒(MPXV)的特异性抗病毒药物和预防性疫苗,该疫情已导致国际关注的突发公共卫生事件的宣布。作为新疫苗的一个发展方向,基于MPXV抗原蛋白的亚单位疫苗的研究尚属空白。在本研究中,MPXV的A29L、M1R、A35R和B6R从原核系统中表达并纯化。将这四种MPXV抗原蛋白组合后与氢氧化铝或CpG7909作为佐剂混合,随后用于接种小鼠。酶联免疫吸附测定(ELISA)、流式细胞术分析和酶联免疫斑点(ELISPOT)测定结果表明,A29L、M1R、A35R和B6R在小鼠中引发了高水平的抗原特异性抗体和基于CD4 T细胞的细胞免疫反应。此外,病毒中和试验结果表明,用四种蛋白免疫的小鼠血清对痘苗病毒具有高中和活性。值得注意的是,ELISA、ELISPOT和病毒中和试验结果还表明,与铝佐剂相比,CpG7909佐剂在诱导免疫反应方面更有效。总之,本研究为进一步研究预防MPXV和其他正痘病毒的亚单位候选疫苗提供了有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fc7/10537547/a4e250c82a37/vaccines-11-01420-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fc7/10537547/99c66b273ff7/vaccines-11-01420-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fc7/10537547/eb8b00531ecd/vaccines-11-01420-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fc7/10537547/5cd87524a135/vaccines-11-01420-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fc7/10537547/a4e250c82a37/vaccines-11-01420-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fc7/10537547/99c66b273ff7/vaccines-11-01420-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fc7/10537547/eb8b00531ecd/vaccines-11-01420-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fc7/10537547/5cd87524a135/vaccines-11-01420-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fc7/10537547/a4e250c82a37/vaccines-11-01420-g004.jpg

相似文献

1
A Subunit Vaccine Candidate Composed of Mpox Virus A29L, M1R, A35R, and B6R Elicits Robust Immune Response in Mice.一种由猴痘病毒A29L、M1R、A35R和B6R组成的亚单位候选疫苗在小鼠中引发强烈免疫反应。
Vaccines (Basel). 2023 Aug 25;11(9):1420. doi: 10.3390/vaccines11091420.
2
Evaluation and comparison of immune responses induced by two Mpox mRNA vaccine candidates in mice.两种痘苗病毒 mRNA 疫苗候选物在小鼠中诱导的免疫应答的评估和比较。
J Med Virol. 2023 Oct;95(10):e29140. doi: 10.1002/jmv.29140.
3
Polyvalent mpox mRNA vaccines elicit robust immune responses and confer potent protection against vaccinia virus.多价 mpox mRNA 疫苗可诱导强烈的免疫应答,并对牛痘病毒提供强大的保护。
Cell Rep. 2024 Jun 25;43(6):114269. doi: 10.1016/j.celrep.2024.114269. Epub 2024 May 23.
4
Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge.A29L、M1R、A35R 和 B6R 重组蛋白疫苗可保护小鼠免受猴痘病毒攻击。
Front Immunol. 2023 Jun 26;14:1203410. doi: 10.3389/fimmu.2023.1203410. eCollection 2023.
5
Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virus.重组多组分亚单位疫苗诱导针对猴痘病毒的高效中和抗体的系统评价
Vaccine. 2024 Dec 2;42(26):126384. doi: 10.1016/j.vaccine.2024.126384. Epub 2024 Sep 24.
6
Rational development of multicomponent mRNA vaccine candidates against mpox.针对猴痘的多组分 mRNA 疫苗候选物的合理开发。
Emerg Microbes Infect. 2023 Dec;12(1):2192815. doi: 10.1080/22221751.2023.2192815.
7
Three neutralizing mAbs induced by MPXV A29L protein recognizing different epitopes act synergistically against orthopoxvirus.三种由 MPXV A29L 蛋白诱导的中和单抗识别不同表位,协同作用抵抗正痘病毒。
Emerg Microbes Infect. 2023 Dec;12(2):2223669. doi: 10.1080/22221751.2023.2223669.
8
Immunogenic proteins and potential delivery platforms for mpox virus vaccine development: A rapid review.免疫原性蛋白和用于天花病毒疫苗开发的潜在传递平台:快速综述。
Int J Biol Macromol. 2023 Aug 1;245:125515. doi: 10.1016/j.ijbiomac.2023.125515. Epub 2023 Jun 21.
9
Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus.天花疫苗的体液免疫持续时间及其与猴痘病毒的交叉反应。
Signal Transduct Target Ther. 2023 Sep 15;8(1):350. doi: 10.1038/s41392-023-01574-6.
10
Single-chain A35R-M1R-B6R trivalent mRNA vaccines protect mice against both mpox virus and vaccinia virus.单价 A35R-M1R-B6R 三价 mRNA 疫苗可预防猴痘病毒和牛痘病毒感染。
EBioMedicine. 2024 Nov;109:105392. doi: 10.1016/j.ebiom.2024.105392. Epub 2024 Oct 18.

引用本文的文献

1
Current status of next-generation vaccines against mpox virus: a scoping review.抗猴痘病毒的下一代疫苗的现状:一项范围综述
Front Pharmacol. 2025 Apr 28;16:1533533. doi: 10.3389/fphar.2025.1533533. eCollection 2025.
2
Rational mpox vaccine design: immunogenicity and protective effect of individual and multicomponent proteins in mice.合理的猴痘疫苗设计:小鼠中单个和多组分蛋白的免疫原性及保护作用
Emerg Microbes Infect. 2025 Dec;14(1):2482702. doi: 10.1080/22221751.2025.2482702. Epub 2025 Mar 27.
3
Chemical cross-linking facilitates antigen uptake and presentation and provides improved protection from Mpox with a dual-antigen subunit vaccine.

本文引用的文献

1
Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice.Mpox 病毒 mRNA-脂质纳米颗粒疫苗候选物在小鼠中引发抗体反应,并针对牛痘病毒挑战提供保护。
Antiviral Res. 2023 Aug;216:105668. doi: 10.1016/j.antiviral.2023.105668. Epub 2023 Jul 8.
2
Suspected case of monkeypox reinfection versus reactivation in a immunocompetent patient, Barcelona, 2022.2022 年,巴塞罗那一名免疫功能正常的患者疑似猴痘再感染与再激活病例。
Int J STD AIDS. 2023 Aug;34(9):649-652. doi: 10.1177/09564624231162426. Epub 2023 Apr 26.
3
Two individuals with potential monkeypox virus reinfection.
化学交联促进抗原摄取和呈递,并通过双抗原亚单位疫苗增强对猴痘的保护作用。
MedComm (2020). 2025 Jan 8;6(1):e70045. doi: 10.1002/mco2.70045. eCollection 2025 Jan.
4
Multi-Component Protein Vaccine Induces a Strong and Long-Term Immune Response Against Monkeypox Virus.多组分蛋白质疫苗可诱导针对猴痘病毒的强烈且长期的免疫反应。
Vaccines (Basel). 2024 Dec 13;12(12):1410. doi: 10.3390/vaccines12121410.
5
Longitudinal viral shedding and antibody response characteristics of men with acute infection of monkeypox virus: a prospective cohort study.急性猴痘病毒感染男性患者的病毒纵向脱落和抗体反应特征:一项前瞻性队列研究。
Nat Commun. 2024 May 27;15(1):4488. doi: 10.1038/s41467-024-48754-8.
6
A cross-sectional investigation of factors influencing mpox vaccine hesitancy for students in Southwest China.西南地区影响学生接种猴痘疫苗犹豫因素的横断面调查。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2309704. doi: 10.1080/21645515.2024.2309704. Epub 2024 Feb 1.
两名有猴痘病毒再次感染可能的个体。
Lancet Infect Dis. 2023 May;23(5):522-524. doi: 10.1016/S1473-3099(23)00185-8. Epub 2023 Apr 6.
4
Rational development of multicomponent mRNA vaccine candidates against mpox.针对猴痘的多组分 mRNA 疫苗候选物的合理开发。
Emerg Microbes Infect. 2023 Dec;12(1):2192815. doi: 10.1080/22221751.2023.2192815.
5
A Case of Mpox Reinfection.一例猴痘再感染病例。
Clin Infect Dis. 2023 Jul 5;77(1):135-137. doi: 10.1093/cid/ciad147.
6
Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigens.多价mRNA疫苗接种引发了针对猴痘病毒表面抗原的强烈免疫反应。
Cell Res. 2023 May;33(5):407-410. doi: 10.1038/s41422-023-00792-5. Epub 2023 Mar 6.
7
Case of apparent mpox reinfection.疑似猴痘再感染病例。
Sex Transm Infect. 2023 Jun;99(4):283-284. doi: 10.1136/sextrans-2022-055736. Epub 2023 Jan 27.
8
Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination.在先前接种过天花或猴痘疫苗的个体中出现突破性猴痘感染。
J Infect. 2023 Feb;86(2):154-225. doi: 10.1016/j.jinf.2022.12.001. Epub 2022 Dec 5.
9
Breakthrough Infections after Postexposure Vaccination against Mpox.接触后接种猴痘疫苗后的突破性感染
N Engl J Med. 2022 Dec 29;387(26):2477-2479. doi: 10.1056/NEJMc2211944. Epub 2022 Dec 7.
10
Strategy of developing nucleic acid-based universal monkeypox vaccine candidates.开发基于核酸的通用猴痘疫苗候选物的策略。
Front Immunol. 2022 Oct 27;13:1050309. doi: 10.3389/fimmu.2022.1050309. eCollection 2022.